Jan 22
Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis
Drugs
For Health Professionals
FDA Collaborates with Health Professional Societies, Trade Associations, and Academia
Topic Paragraphs
Call-To-Action Title
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
Call-To-Action Title
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
December 4, 2024 - Clinicians hear directly from the CDC, FDA, HHS, and NIH about what we can do to address the recent surge in syphilis and its impact on individuals, pregnant people and babies.
Learn More
Subscribe to our e-newsletter
We know you're busy! The easiest way to keep up with us is to subscribe to our weekly e-newsletter.
You'll get the latest announcements, regulations, and upcoming events delivered to your email inbox every Monday.
How to Report Adverse Events to FDA MedWatch
Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products.
Learn More
Clinicians Connect: Conversations with FDA's Chief Medical Officer
Join FDA’s Chief Medical Officer for a clinically focused conversation that will cover a different topic each meeting. For more information, subscribe to our mailing list.
Subscribe to the Clinicians Connect mailing listParagraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Vaccines for COVID-19: A Personal Reflection
Vaccines for Covid-19: A Personal Reflection by Robert M. Califf, MD
CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
The 2024 New Drug Therapy Approvals report features drug approvals that CDER considers likely to have a significant impact on public health.
Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum
FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.
Reach out today to talk about collaborating!
Public Engagement Staff
Office of External Affairs
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993
United States
Office of External Affairs
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993
United States
Hours Available
Public Engagement Staff
Paragraph Header (Column 2)
MedWatch Safety Alerts on X:
Paragraph Header (Column 2)
MedWatch Safety Alerts on X:
MedWatch
FDA MedWatch Safety Information
You know the moment it happens.
Follow @FDAMedWatch